Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More than half of the therapies in positive industry-sponsored Phase III trials don’t help people with cancer live longer.
10 Strategies to Keep Costs Under Control
Experts are questioning whether the groups’ financial ties could push them to put drugmakers’ interests ahead of the people they represent...
The way we develop new treatments for cancer does always lead to better survival time, and rarely leads to better quality of life.
Stop me if you’ve heard this one before.
Oncologist and health economist Gary Lyman, MD, MPH, discusses a class of treatments on the rise. Will lower prices follow?
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”
Puerto Rico’s main exports are medical devices and pharmaceuticals, including HIV and cancer drugs.
Scott Gottlieb has said he wants lower costs and faster drug approvals.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.